Automated measurement of nerve fiber density using line intensity scan analysis

Journal of Neuroscience Methods

Volumn 206, Issue 2, 2012, Pages 165-175

  Sathyanesan, Aaron ^a   Ogura, Tatsuya ^a   Lin, Weihong ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

Cholinergic nerve fiber density; Cortex; Epifluorescence image; Hessian based feature extraction; Hippocampus; Line intensity scan analysis

Indexed keywords

GREEN FLUORESCENT PROTEIN; VESICULAR ACETYLCHOLINE TRANSPORTER;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN CORTEX; C57BL 6 MOUSE; CHOLINERGIC NERVE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; LINE INTENSITY SCAN ANALYSIS; MALE; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; CEREBRAL CORTEX; CHOLINERGIC NEURONS; FEMALE; FLUORESCENT DYES; HIPPOCAMPUS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICE; MICROSCOPY, FLUORESCENCE; NERVE FIBERS;

EID: 84858730670     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2012.02.019     Document Type: Article

References (46)

1. Aznavour N., Mechawar N., Descarries L. Comparative analysis of cholinergic innervation in the dorsal hippocampus of adult mouse and rat: a quantitative immunocytochemical study. Hippocampus 2002, 12:206-217.
2. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 1995, 64:749-760.
3. Boncristiano S., Calhoun M.E., Kelly P.H., Pfeifer M., Bondolfi L., Stalder M., et al. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci 2002, 22:3234-3243.
4. Bonin T., Franke G., Hagen-Eggert M., Koch P., Huttmann G. In vivo Fourier-domain full-field OCT of the human retina with 1.5 million A-lines/s. Opt Lett 2010, 35:3432-3434.
5. Bronfman F.C., Moechars D., Van Leuven F. Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice. Neurobiol Dis 2000, 7:152-168.
6. Casanova-Molla J., Morales M., Sola-Valls N., Bosch A., Calvo M., Grau-Junyent J.M., et al. Axonal fluorescence quantitation provides a new approach to assess cutaneous innervation. J Neurosci Methods 2011, 200:190-198.
7. Frangi A.F., Niessen W.J., Vincken K.L., Viergever M.A. Multiscale vessel enhancement filtering. Lect Notes Comput Sci 1998, 1496:130-137.
8. Frotscher M., Schlander M., Leranth C. Cholinergic neurons in the hippocampus. A combined light- and electron-microscopic immunocytochemical study in the rat. Cell Tissue Res 1986, 246:293-301.
9. Geula C., Mesulam M.M. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cereb Cortex 1996, 6:165-177.
10. Ghosh S., Gepstein S., Heikkila J.J., Dumbroff E.B. Use of a scanning densitometer or an ELISA plate reader for measurement of nanogram amounts of protein in crude extracts from biological tissues. Anal Biochem 1988, 169:227-233.
11. Grider M.H., Chen Q., Shine H.D. Semi-automated quantification of axonal densities in labeled CNS tissue. J Neurosci Methods 2006, 155:172-179.
12. Hladuvka J., Groller E. Exploiting the Hessian matrix for content-based retrieval of volume-data features. Visual Comput 2002, 18:207-217.
13. Ikonomovic M.D., Abrahamson E.E., Isanski B.A., Wuu J., Mufson E.J., DeKosky S.T. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease. Arch Neurol 2007, 64:1312-1317.
14. Jellinger K., Braak H., Braak E., Fischer P. Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Ann N Y Acad Sci 1991, 640:203-209.
15. Kastner M. Protein liquid chromatography 2000, Elsevier, Amsterdam/New York. 1st ed.
16. Kuhl D.E., Minoshima S., Fessler J.A., Frey K.A., Foster N.L., Ficaro E.P., et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol 1996, 40:399-410.
17. Lauria G., Hsieh S.T., Johansson O., Kennedy W.R., Leger J.M., Mellgren S.I., et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe-deration of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010, 17:903-949.
18. Lehmann K., Hundsdorfer B., Hartmann T., Teuchert-Noodt G. The acetylcholine fiber density of the neocortex is altered by isolated rearing and early methamphetamine intoxication in rodents. Exp Neurol 2004, 189:131-140.
19. Li Y.P., Liu W.C., Oo T.F., Wang L., Tang Y., Jackson-Lewis V., et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 2009, 12:826-828.
20. Liu Z.W., Zhang R.L., Li Y., Cui Y.S., Chopp M. Remodeling of the corticospinal innervation and spontaneous behavioral recovery after ischemic stroke in adult mice. Stroke 2009, 40:2546-2551.
21. Maguire E.A., Gadian D.G., Johnsrude I.S., Good C.D., Ashburner J., Frackowiak R.S., et al. Navigation-related structural change in the hippocampi of taxi drivers. Proc Natl Acad Sci USA 2000, 97:4398-4403.
22. Mandl R.C., Schnack H.G., Zwiers M.P., van der Schaaf A., Kahn R.S., Hulshoff Pol HE Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. PLoS One 2008, 3:e3631.
23. Marina N., Bull N.D., Martin K.R. A semiautomated targeted sampling method to assess optic nerve axonal loss in a rat model of glaucoma. Nat Protoc 2010, 5:1642-1651.
24. Mechawar N., Cozzari C., Descarries L. Cholinergic innervation in adult rat cerebral cortex: a quantitative immunocytochemical description. J Comp Neurol 2000, 428:305-318.
25. Meijering E. FeatureJ: A Java Package for Image Feature Extraction 2003, http://www.imagescience.org/meijering/software/featurej/.
26. Misgeld T., Kerschensteiner M. In vivo imaging of the diseased nervous system. Nat Rev Neurosci 2006, 7:449-463.
27. Mitchell S.J., Rawlins J.N., Steward O., Olton D.S. Medial septal area lesions disrupt theta rhythm and cholinergic staining in medial entorhinal cortex and produce impaired radial arm maze behavior in rats. J Neurosci 1982, 2:292-302.
28. Nieuwenhuys R., Donkelaar H.J.T., Nicholson C. The central nervous system of vertebrates 1998, Springer, Berlin, New York.
29. Nolano M., Provitera V., Caporaso G., Stancanelli A., Vitale D.F., Santoro L. Quantification of pilomotor nerves. A new tool to evaluate autonomic involvement in diabetes. Neurology 2010, 75:1089-1097.
30. Ogura T., Krosnowski K., Zhang L., Bekkerman M., Lin W. Chemoreception regulates chemical access to mouse vomeronasal organ: role of solitary chemosensory cells. PloS One 2010, 5:e11924.
31. Ogura T., Szebenyi S.A., Krosnowski K., Sathyanesan A., Jackson J., Lin W. Cholinergic microvillous cells in the mouse main olfactory epithelium and effect of acetylcholine on olfactory sensory neurons and supporting cells. J Neurophysiol 2011, 106:1274-1287.
32. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego. 2nd ed.
33. Ramer L.M., McPhail L.T., Borisoff J.F., Soril L.J.J., Kaan T.K.Y., Lee J.H.T., et al. Endogenous TrkB ligands suppress functional mechanosensory plasticity in the deafferented spinal cord. J Neurosci 2007, 27:5812-5822.
34. Ransmayr G., Cervera P., Hirsch E.C., Berger W., Fischer W., Agid Y. Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology. Neuroscience 1992, 47:843-851.
35. Sato Y., Nakajima S., Shiraga N., Atsumi H., Yoshida S., Koller T., et al. Three-dimensional multi-scale line filter for segmentation and visualization of curvilinear structures in medical images. Med Image Anal 1998, 2:143-168.
36. Schols L., Bauer P., Schmidt T., Schulte T., Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004, 3:291-304.
37. Scott R.P.W. Techniques and practice of chromatography 1995, New York, Marcel Dekker.
38. Shepherd G.M., Raastad M., Andersen P. General and variable features of varicosity spacing along unmyelinated axons in the hippocampus and cerebellum. Proc Natl Acad Sci USA 2002, 99:6340-6345.
39. Soghomonian J.J., Doucet G., Descarries L. Serotonin innervation in adult rat neostriatum. I. Quantified regional distribution. Brain Res 1987, 425:85-100.
40. Squire L.R., Ojemann J.G., Miezin F.M., Petersen S.E., Videen T.O., Raichle M.E. Activation of the hippocampus in normal humans: a functional anatomical study of memory. Proc Natl Acad Sci USA 1992, 89:1837-1841.
41. Tandan R., Bradley W.G. Amyotrophic lateral sclerosis. Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol 1985, 18:271-280.
42. Trauth J.A., McCook E.C., Seidler F.J., Slotkin T.A. Modeling adolescent nicotine exposure: effects on cholinergic systems in rat brain regions. Brain Res 2000, 873:18-25.
43. Vonsattel J.P., DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 1998, 57:369-384.
44. Whitney M.A., Crisp J.L., Nguyen L.T., Friedman B., Gross L.A., Steinbach P., et al. Fluorescent peptides highlight peripheral nerves during surgery in mice. Nat Biotechnol 2011, 29:352-356.
45. Wong T.P., Debeir T., Duff K., Cuello A.C. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J Neurosci 1999, 19:2706-2716.
46. Ziehn M.O., Avedisian A.A., Tiwari-Woodruff S., Voskuhl R.R. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab Invest 2010, 90:774-786.